Search Results - Catharina Gerhards

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines

    Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-... by Catharina Gerhards, Margot Thiaucourt, Michael Hetjens, Verena Haselmann, Michael Neumaier, Maximilian Kittel

    Published 2023-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Expression of ADP receptor P2Y12, thromboxane A2 receptor and C-type lectin-like receptor 2 in cord blood-derived megakaryopoiesis

    Expression of ADP receptor P2Y12, thromboxane A2 receptor and C-type lectin-like receptor 2 in cord blood-derived megakaryopoiesis by Catharina Gerhards, Stefanie Uhlig, Mani Etemad, Foteini Christodoulou, Karen Bieback, Harald Klüter, Peter Bugert

    Published 2021-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay

    Specificity testing by point prevalence as a simple assessment strategy using the Roche Elecsys® anti-SARS-CoV-2 immunoassay by Maximilian Kittel, Peter Findeisen, Maria-Christina Muth, Margot Thiaucourt, Catharina Gerhards, Michael Neumaier, Verena Haselmann

    Published 2021-04-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection

    Longitudinal assessment of anti-SARS-CoV-2 antibody dynamics and clinical features following convalescence from a COVID-19 infection by Catharina Gerhards, Margot Thiaucourt, Maximilian Kittel, Celine Becker, Volker Ast, Michael Hetjens, Michael Neumaier, Verena Haselmann

    Published 2021-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    The Impact of Clinical Factors and SARS-CoV-2 Variants on Antibody Production in Vaccinated German Healthcare Professionals Infected Either with the Delta or the Omicron Variant

    The Impact of Clinical Factors and SARS-CoV-2 Variants on Antibody Production in Vaccinated German Healthcare Professionals Infected Either with the Delta or the Omicron Variant by Catharina Gerhards, Marlene Steingass, Alexandra Heininger, Bettina Lange, Michael Hetjens, Marlis Gerigk, Michael Neumaier, Osman Evliyaoglu, Maximilian Kittel

    Published 2024-02-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening Conditions

    Anosmia Testing as Early Detection of SARS-CoV-2 Positivity; A Prospective Study under Screening Conditions by Frederic Jungbauer, Catharina Gerhards, Margot Thiaucourt, Michael Behnes, Nicole Rotter, Angela Schell, Verena Haselmann, Michael Neumaier, Maximilian Kittel

    Published 2022-06-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-Syndrome

    Humoral SARS-CoV-2 Immune Response in COVID-19 Recovered Vaccinated and Unvaccinated Individuals Related to Post-COVID-Syndrome by Catharina Gerhards, Maximilian Kittel, Volker Ast, Peter Bugert, Matthias F. Froelich, Michael Hetjens, Verena Haselmann, Michael Neumaier, Margot Thiaucourt

    Published 2023-02-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Clinical evaluation of commercial automated SARS-CoV-2 immunoassays

    Clinical evaluation of commercial automated SARS-CoV-2 immunoassays by Maximilian Kittel, Maria Christina Muth, Ingrid Zahn, Heinz-Jürgen Roth, Margot Thiaucourt, Catharina Gerhards, Verena Haselmann, Michael Neumaier, Peter Findeisen

    Published 2021-02-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Exploring the Synergistic Potential of Radiomics and Laboratory Biomarkers for Enhanced Identification of Vulnerable COVID-19 Patients

    Exploring the Synergistic Potential of Radiomics and Laboratory Biomarkers for Enhanced Identification of Vulnerable COVID-19 Patients by Catharina Gerhards, Verena Haselmann, Samuel F. Schaible, Volker Ast, Maximilian Kittel, Manfred Thiel, Alexander Hertel, Stefan O. Schoenberg, Michael Neumaier, Matthias F. Froelich

    Published 2023-07-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2

    Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2 by Feyza Gül Özbay Kurt, Feyza Gül Özbay Kurt, Feyza Gül Özbay Kurt, Feyza Gül Özbay Kurt, Alisa Lepper, Alisa Lepper, Alisa Lepper, Alisa Lepper, Catharina Gerhards, Mathis Roemer, Samantha Lasser, Samantha Lasser, Samantha Lasser, Samantha Lasser, Ihor Arkhypov, Ihor Arkhypov, Ihor Arkhypov, Ihor Arkhypov, Rebekka Bitsch, Rebekka Bitsch, Rebekka Bitsch, Rebekka Bitsch, Peter Bugert, Peter Altevogt, Peter Altevogt, Peter Altevogt, Peter Altevogt, Cécile Gouttefangeas, Michael Neumaier, Jochen Utikal, Jochen Utikal, Jochen Utikal, Jochen Utikal, Viktor Umansky, Viktor Umansky, Viktor Umansky, Viktor Umansky

    Published 2022-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: